NCT00558467 - Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2009

Conditions

Tourette Syndrome

Interventions

DRUG

pramipexole immediate release (IR)

DRUG

Placebo

Trial Locations (16)

248.644.0026 Boehringer Ingelheim Investigational Site, Bradenton

248.644.0025 Boehringer Ingelheim Investigational Site, Tampa

248.644.0006 Boehringer Ingelheim Investigational Site, Columbus

248.644.0012 Boehringer Ingelheim Investigational Site, Chicago

248.644.0005 Boehringer Ingelheim Investigational Site, Cambridge

248.644.0003 Boehringer Ingelheim Investigational Site, Manhasset

248.644.0009 Boehringer Ingelheim Investigational Site, New York

248.644.0018 Boehringer Ingelheim Investigational Site, New York

248.644.0013 Boehringer Ingelheim Investigational Site, Orangeburg

248.644.0029 Boehringer Ingelheim Investigational Site, Oklahoma City

248.644.0010 Boehringer Ingelheim Investigational Site, Providence

248.644.0030 Boehringer Ingelheim Investigational Site, Memphis

248.644.0008 Boehringer Ingelheim Investigational Site, Houston

248.644.0023 Boehringer Ingelheim Investigational Site, Norfolk

248.644.49001 Boehringer Ingelheim Investigational Site, Hanover

248.644.49004 Boehringer Ingelheim Investigational Site, Ulm